Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niacin sustained-release capsules in RA with dyslipidemia
NCT07004725Phase 2Not yet recruiting
- Sponsor
- Peking University People's Hospital
- Start
- May 2025
- Primary completion
- Jan 2027
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of niacin in rheumatoid arthritis (RA), dyslipidemia, sponsored by Peking University People's Hospital. Planned start May 2025; status: not yet recruiting.
02
Drugs
niacin
03
Conditions
rheumatoid arthritis (RA)dyslipidemia
Beyond the preview
Go deeper on NCT07004725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07004725.